EDGAR Filing Documents for 0000950170-24-041814

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0000950170-24-041814

Filing Date

2024-04-04

Accepted

2024-04-04 16:15:47

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	rgnx-2024-proxy-addition.htm	DEFA14A	9402
2	GRAPHIC	img176235482_0.jpg	GRAPHIC	625096
3	GRAPHIC	img176235482_1.jpg	GRAPHIC	245505
	Complete submission text file	0000950170-24-041814.txt		1209199

Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850

Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181

REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37553 | Film No.: 24823307
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)